An Observational Study of Patients With Chronic Kidney Disease

Target PharmaSolutions, Inc.

Overview

TARGET-KIDNEY is an observational research study to conduct a comprehensive review of outcomes for patients with chronic kidney disease (CKD) and end-stage renal disease (ESKD).

Study Type

OBSERVATIONAL

Conditions

Kidney Disease, Chronic End Stage Kidney Disease

Interventions

ObservationalOTHER

Observational

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Disease Cohort Inclusion Criteria: * Adult\* patients at the time of enrollment with a diagnosis of CKD/ESKD by ICD-10 code in the EHR interface Exclusion Criteria: * Death * Manual removal (sponsor or site request) * No EHR interface encounter \> 3 years Engaged Cohort Inclusion Criteria: * Adult \* patients diagnosed and managed for CKD/ESKD invited to participate * Ability to provide written informed consent Exclusion Criteria: * Patient expressed desire to withdraw consent to complete PROs * Failure to complete PROs within 24 weeks of initial invitation * Greater than 24 months lapse of survey completion after baseline surveys completed * Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

Outcomes

Primary Outcomes

To characterize the natural history of disease in patients with CKD/ESKD.

Time frame: 20 Years

To assess safety and effectiveness of CKD/ESKD treatments and treatments for complications of either condition

Time frame: 20 Years

Secondary Outcomes

To evaluate provider management practices in the treatment of patients with CKD/ESKD

Time frame: 20 Years

To evaluate longitudinal and patient reported outcomes in CKD/ESKD

Time frame: 20 Years

To select and evaluate quality of care measures for patients with CKD/ESKD

Time frame: 20 Years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.